Practical recognition tools of immunoglobulin  G serum antibodies against the myelin oligodendrocyte glycoprotein‐positive optic neuritis and its clinical implications
In this review, we discuss the clinical and paraclinical features of immunoglobulin  G serum antibodies against myelin oligodendrocyte glycoprotein‐positive optic neuritis in adults, and focus on the distinctive features that can enable its early diagnosis. Therapeutical considerations at the acute stage and for relapse prevention are further deliberated. AbstractMyelin oligodendrocyte glycoprotein (MOG) ‐associated disease is an autoimmune disease of the central nervous system, associated with the presence of immunoglobulin G serum antibodies against MOG. Recent data have allowed characterization of the clinical spe...
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Itay Lotan, Frederike C. Oertel, Claudia Chien, Susanna Asseyer, Friedemann Paul, Hadas Stiebel ‐Kalish Tags: REVIEW ARTICLE Source Type: research

Treatment of myelin oligodendrocyte glycoprotein immunoglobulin  G–associated disease
This review summarizes the current understanding of acute and chronic treatments for MOGAD. Timing and duration of treatment, pregnancy, and emerging therapies are also discussed. AbstractMyelin oligodendrocyte glycoprotein (MOG) immunoglobulin  G (IgG)–associated disease (MOGAD) is increasingly recognized as a distinct nosological entity from aquaporin‐4 antibody IgG–positive neuromyelitis optica spectrum disorder (AQP4‐IgG NMOSD). The advent of highly specific MOG‐IgG cell‐based diagnostic assays have helped to refine our un derstanding of the clinical spectrum of MOGAD. To date, treatment approaches have be...
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Sarah Healy, Kariem Tarik Elhadd, Emily Gibbons, Dan Whittam, Michael Griffiths, Anu Jacob, Saif Huda Tags: REVIEW ARTICLE Source Type: research

Issue Information
(Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Tags: Issue Information Source Type: research

Recent advances in the understanding of myelin oligodendrocyte glycoprotein antibody –associated disorders
(Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Ichiro Nakashima Tags: EDITORIAL Source Type: research

Lenalidomide ‐associated progressive multifocal leukoencephalopathy
ConclusionsAlthough rare, lenalidomide ‐induced PML should be considered in myeloma patients treated with lenalidomide. (Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Kazutaka Nishimura, Yuta Iwai, Mariko Yabuki, Hiroe Fuse, Kazuo Nakamichi, Kenta Takahashi, Tadaki Suzuki, Masayuki Saijo, Takeshi Fukushima, Satoshi Kuwabara Tags: CASE REPORT Source Type: research

Circulating inflammatory cytokine levels correlates with cognitive impairment
ConclusionThe TNF ‐α and IL‐6 levels are significantly higher in patients with moderate‐severe stage of AD. Inflammatory cytokine levels might predict the cognitive impairment severity in AD patients. (Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Leila Rasi Marzabadi, Saeed Sadigh ‐Eteghad, Mahnaz Talebi Tags: ORIGINAL ARTICLE Source Type: research

Magnetic resonance imaging of Bal ó’s concentric sclerosis: Literature review and presentation of two focused cases
This review aims to describe two cases of Bal ò’s Concentric Sclerosis (BCS) and to review the state‐of‐the‐art literature. Through the analysis of current imaging practice, our purpose is to help clinicians reach early diagnosis, thus enhancing the chances of a more successful outcome for the patients. AbstractThe aim of this study was to describe two cases of Bal ó’s concentric sclerosis, and to review the state‐of‐the‐art literature. This dissertation is the result of a critical analysis matching the literature and our professional experience. Data were synthesized into a narrative review. BCS is often...
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Chiara Ballini, Francesco Destro, Paolo Garofalo, Jasjit S. Suri, Tommaso Ercoli, Antonella Muroni, Giancarlo Caddeo, Yang Qi, Giovanni Defazio, Luca Saba Tags: REVIEW ARTICLE Source Type: research

Congress report of 16th International Child Neurology Congress/49th annual Child Neurology Society meeting: Virtual 2020
(Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Ayuko Igarashi Tags: CONGRESS REPORT Source Type: research

Voltage ‐gated potassium channel complex (VGKC) antibody encephalitis in a Filipino adult: A reversible cause of early‐onset neurocognitive disorder
ConclusionThis case highlights VGKC antibody encephalitis as an important diagnostic consideration in patients presenting with subacute onset of memory loss, behavioral changes, and seizures. With prompt initiation of immunosuppressive therapy, neurocognitive changes can be potentially reversed. (Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Ferron F. Ocampo, Edmundo G. Saniel, Ma. Socorro C. Martinez Tags: CASE REPORT Source Type: research

Pathology of myelin oligodendrocyte glycoprotein antibody –associated disease
The difference of pathological mechanisms in myelin oligodendrocyte glycoprotein (MOG) and aquaporin ‐4 (AQP4) antibody. (Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Tatsuro Misu Tags: NEW DEVELOPMENTS IN NEUROIMMUNOLOGY Source Type: research

Announcement of 2018 Clinical and Experimental Neuroimmunology Best Article award
(Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Hiroyuki Murai Tags: AWARD ANNOUNCEMENT Source Type: research

A thank you note to our reviewers
(Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Tags: ACKNOWLEDGEMENT Source Type: research

Treatment of myelin oligodendrocyte glycoprotein immunoglobulin  G–associated disease
This review summarizes the current understanding of acute and chronic treatments for MOGAD. Timing and duration of treatment, pregnancy, and emerging therapies are also discussed. AbstractMyelin oligodendrocyte glycoprotein (MOG) immunoglobulin  G (IgG)–associated disease (MOGAD) is increasingly recognized as a distinct nosological entity from aquaporin‐4 antibody IgG–positive neuromyelitis optica spectrum disorder (AQP4‐IgG NMOSD). The advent of highly specific MOG‐IgG cell‐based diagnostic assays have helped to refine our un derstanding of the clinical spectrum of MOGAD. To date, treatment approaches have be...
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Authors: Sarah Healy, Kariem Tarik Elhadd, Emily Gibbons, Dan Whittam, Michael Griffiths, Anu Jacob, Saif Huda Tags: REVIEW ARTICLE Source Type: research

Issue Information
(Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Tags: Issue Information Source Type: research

A thank you note to our reviewers
(Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - February 18, 2021 Category: Neurology Tags: ACKNOWLEDGEMENT Source Type: research